Section 6, Therapeutics, starts with individual psychoanalytic psychotherapy and continues with chapters on group, family, time-limited, and cognitive techniques. Issues of practical importance are presented, such as termination of therapy, combined approaches, limitations of response, ethical implications of treatment, and ethnic and cultural perspectives on psychopharmacology (a key to dispelling the "color-blind approach"). The chapter on antipsychotic drugs, another of the many excellent chapters in volume 2, provides a balanced discussion about the "clinical superiority" of some psychotropic agents over others, and it describes the concept of treatment resistance. There are excellent reviews on pharmacogenomics, and the last paragraph of the chapter on mood stabilizers is an inspiring call for comprehensiveness. Throughout these chapters, the clinician in search of practical advice has to wonder whether to go to the chapters on clinical entities or to those specifically devoted to pharmacological treatments, such is the richness of the material in both. I was also impressed by the comprehensiveness and thoroughness of the chapter on therapeutic management of the suicidal patient, appropriately complemented by those on treatment of violent behavior and on compliance, among others.